Remédio ajudaria pacientes que têm mais chances de morrer

In pre-clinical tests, drug has a good response in combating inflammation associated with Covid

Experiments with animals and human cells carried out at USP (University of São Paulo) suggest that niclosamide, an already widely used vermifuge, would have antiviral action and could inhibit the exacerbated inflammatory response that often leads to death in patients with the severe form of Covid. -19. Further studies are still needed to find out …

In pre-clinical tests, drug has a good response in combating inflammation associated with Covid Read More »